SCHEMBL8375145

SCHEMBL8375145

CCN(CC)C(=O)O.Oc1cnccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.44
GFER P55789 1/20 0.44
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
BLM P54132 1/20 0.37
P2RX4 Q99571 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KDM4C Q9H3R0 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375129 0.81 KDM4E (0.45) LMNAGFERCYP2C9CYP2C19MEN1
SCHEMBL8375861 0.80 P2RX4 (0.39) LMNAGFERCYP2C9CYP2C19MEN1
SCHEMBL8376698 0.78 KDM4C (0.43) LMNACYP2C9CYP2C19MEN1MAPT
SCHEMBL29947377 0.77
SCHEMBL316645 0.77
SCHEMBL8376711 0.77 HSD17B10 (0.42) LMNAGFERMAPTP2RX4TSHR
SCHEMBL8375142 0.76 KDM4C (0.58) LMNAP2RX4HSD17B10KDM4CKDM6B
SCHEMBL17438490 0.76 LMNA (0.47) LMNAGFERMEN1MAPTKMT2A
Ammonia Solution, Strong SCHEMBL28048774 0.75
SCHEMBL9654632 0.75 ALDH1A1 (0.37) LMNAGFERCYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP disclosed